geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Anti-tumor activities of peptides corresponding to conserved complementary determining regions from different immunoglobulins


, : Anti-tumor activities of peptides corresponding to conserved complementary determining regions from different immunoglobulins. Peptides 59: 14-19

Short synthetic peptides corresponding to sequences of complementarity-determining regions (CDRs) from different immunoglobulin families have been shown to induce antimicrobial, antiviral and antitumor activities regardless of the specificity of the original monoclonal antibody (mAb). Presently, we studied the in vitro and in vivo antitumor activity of synthetic peptides derived from conserved CDR sequences of different immunoglobulins against human tumor cell lines and murine B16F10-Nex2 melanoma aiming at the discovery of candidate molecules for cancer therapy. Four light- and heavy-chain CDR peptide sequences from different antibodies (C36-L1, HA9-H2, 1-H2 and Mg16-H2) showed cytotoxic activity against murine melanoma and a panel of human tumor cell lineages in vitro. Importantly, they also exerted anti-metastatic activity using a syngeneic melanoma model in mice. Other peptides (D07-H3, MN20v1, MS2-H3) were also protective against metastatic melanoma, without showing significant cytotoxicity against tumor cells in vitro. In this case, we suggest that these peptides may act as immune adjuvants in vivo. As observed, peptides induced nitric oxide production in bone-marrow macrophages showing that innate immune cells can also be modulated by these CDR peptides. The present screening supports the search in immunoglobulins of rather frequent CDR sequences that are endowed with specific antitumor properties and may be candidates to be developed as anti-cancer drugs.

US$19.90

PMID: 24972300

DOI: 10.1016/j.peptides.2014.06.007


Other references

Isayeva A.B., 1974: Variation of the Mo/ W ratio as a function of sedimentation conditions. Oceanology 14(3): 409-412

Chang, A.C.; Salomon, D.R.; Wadsworth, S., 1995: A3b1 and a6b1 integrins mediate laminin/merosin binding and function as costimulatory molecules for human thymocyte proliferation. Journal of Immunology 154: 0-10

Schiltenwolf, M.; Martini, A.K., 1994: Natural course in lunate necrosis. Reconstruction of the natural course of lunate necrosis is difficult because of incomplete findings, especially in the initial stages. The necrosis progresses steadily from initial lunate oedema with a normal X-ray appearance to condensation, frag...

Corner, J.; Clark, D.; Normand, C., 2002: Evaluating the work of clinical nurse specialists in palliative care. Palliative Medicine 16(4): 275-277

Hao, Z.; Wang, D.; Zeng, Y.; Liu, M., 2013: Repetitive transcranial magnetic stimulation for improving function after stroke. It had been assumed that suppressing the undamaged contralesional motor cortex by repetitive low-frequency transcranial magnetic stimulation (rTMS) or increasing the excitability of the damaged hemisphere cortex by high-frequency rTMS will promote...

Denis, H., 1974: Biochemistry of amphibian development. Unknown

Borley, N.C.; Kimber, C.; Ransley, P.G., 2000: An unusual cause of testicular ischaemia. Bju International 85(7): 971-971

Gabin, D.E.; Gispert, S.; Murphy, D.; Auburger, G.; Myers, R.; Nussbaum, R.L., 2003: Deletion of the endogenous mouse SNCA gene markedly exacerbates synucleinopathy in transgenic mice expressing Ala53Thr. American Journal of Human Genetics 73(5): 510, November

L.M.M.rkova; N.A.G.menyuk; M.A.B.labudkin; G.N.B.risov, 1977: Determination of the dispersity of medicinal suspension ointments. Pharmaceutical Chemistry Journal 11(2): 278-279

Zhong, H.; Bowen, J.Phillip., 2005: Theoretical study of stereoselective reduction controlled by NADH analogs. The potential energy surfaces (PES) of 2-methyl-4-(R)-methyl-1,4-dihydropyridine-3-carboxamide (4R-DM, 1), 2-methyl-4-(S)-methyl-1,4-dihydropyridine-3-carboxamide (4S-DM, 2) and 2-methyl-1,4-dihydropyridine-3-carboxamide (MM, 3) have been explored...